RCM
SGMO

RA Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

RA Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,250,000
Closed -$18.8M – 29
2017
Q3 		$18.8M Hold
1,250,000
– – 1.69% 18
2017
Q2 		$11M Buy
+1,250,000
New +$8.02M 1.26% 18
2016
Q4 		– Sell
-899,438
Closed -$4.16M – 32
2016
Q3 		$4.16M Sell
899,438
-266,500
-23% -$1.36M 0.43% 27
2016
Q2 		$6.75M Sell
1,165,938
-1,046,098
-47% -$6.67M 0.93% 21
2016
Q1 		$13.4M Hold
2,212,036
– – 1.71% 17
2015
Q4 		$20.2M Buy
2,212,036
+766,606
+53% +$5.91M 2% 18
2015
Q3 		$8.15M Buy
1,445,430
+225,221
+18% +$1.86M 1.17% 27
2015
Q2 		$13.5M Hold
1,220,209
– – 1.36% 24
2015
Q1 		$19.1M Hold
1,220,209
– – 1.9% 16
2014
Q4 		$18.6M Hold
1,220,209
– – 1.99% 17
2014
Q3 		$13.2M Sell
1,220,209
-1,571,096
-56% -$20.5M 1.56% 20
2014
Q2 		$42.6M Sell
2,791,305
-2,430,748
-47% -$35M 4.31% 8
2014
Q1 		$94.4M Sell
5,222,053
-5,219
-0.1% -$101K 6.77% 4
2013
Q4 		$72.6M Buy
5,227,272
+969,028
+23% +$11.2M 8.46% 3
2013
Q3 		$44.7M Sell
4,258,244
-1,109,850
-21% -$11M 4.66% 7
2013
Q2 		$41.9M Buy
+5,368,094
New +$46.8M 5.56% 5

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RA Capital Management's SGMO Position: Q4 2017 in Review

RA Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2017, closing a stake of 1,250,000 shares — an estimated $18.8M sold.

RA Capital Management first reported a position in SGMO in Q2 2013 and held it in 16 quarters. The position peaked at $94.4M in Q1 2014. 170 funds tracked by Wall St. Rank hold SGMO as of Q4 2017.

  • RA Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2017 after selling out during the quarter.
  • RA Capital Management sold 1,250,000 SANGAMO THERAPEUTICS INC shares in Q4 2017, an estimated $18.8M.
  • RA Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 16 quarters.
  • RA Capital Management's SANGAMO THERAPEUTICS INC position peaked at $94.4M in Q1 2014.
  • 170 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2017.

Based on RA Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.